Comparison of commercial dosimetric software platforms in patients treated with (177)Lu‐DOTATATE for peptide receptor radionuclide therapy

PURPOSE: The aim of this study was to quantitatively compare five commercial dosimetric software platforms based on the analysis of clinical datasets of patients who benefited from peptide receptor radionuclide therapy (PRRT) with (177)Lu‐DOTATATE (LUTATHERA(®)). METHODS: The dosimetric analysis was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med Phys
Main Authors: Mora‐Ramirez, Erick, Santoro, Lore, Cassol, Emmanuelle, Ocampo‐Ramos, Juan C., Clayton, Naomi, Kayal, Gunjan, Chouaf, Soufiane, Trauchessec, Dorian, Pouget, Jean‐Pierre, Kotzki, Pierre‐Olivier, Deshayes, Emmanuel, Bardiès, Manuel
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
COMPUTATIONAL AND EXPERIMENTAL DOSIMETRY
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7589428/
https://ncbi.nlm.nih.gov/pubmed/32632928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mp.14375
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados